Preliminary scientific tests suggest conolidine might inhibit particular ion channels, reducing neuronal excitability and limiting ache alerts. This system is particularly suitable in neuropathic ache, the place irregular signaling will cause persistent discomfort. On top of that, conolidine appears to impact G protein-coupled receptor (GPCR) pathw